id: comorbid_inflammation_metastasis_to_mortality_rate
name: Comorbid Lung Inflammation and Cancer Metastasis â†’ Mortality Rate
from_node:
  node_id: comorbid_inflammation_metastasis
  node_name: Comorbid Lung Inflammation and Cancer Metastasis
to_node:
  node_id: mortality_rate
  node_name: Mortality Rate
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Lung inflammation and cancer metastasis coexist and interact synergistically'
- 'Step 2: Inflammatory processes accelerate cancer progression while cancer impairs
  immune function'
- 'Step 3: Combined burden of inflammation and metastasis overwhelms physiological
  reserves'
- 'Step 4: Multi-system failure and accelerated disease progression increase mortality'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Cong Li et al. 2024. "Conquering dual challenges: A sialic acid-modified
    liposome for targeting activated neutrophils to tackle comorbid lung inflammation
    and cancer metastasis.." *Journal of controlled release : official journal of
    the Controlled Release Society*. https://doi.org/10.1016/j.jconrel.2024.10.048'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.121475'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
